Showing results (291-300 of 584) with videos related to

Sort By:
Pageof 59
Critical Reviews in Oncology/Hematology|February 19, 2011
Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologistsStephane Ederhy, Hassan Izzedine, Christophe Massard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncologyCharles Ferté, Andrew D Trister, Erich Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2022
Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive DiseaseSai-Hong I Ou, Benjamin J Solomon, Alice T Shaw, et al.
Cancers|December 8, 2020
Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung CancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.
Ecancermedicalscience|October 21, 2020
Perspectives on cancer care in older patients in FranceMathilde Hauchecorne, Monica Pierro, Etienne Brain, et al.
Future Oncology (London, England)|August 11, 2022
LIBRETTO-432, a phase III study of adjuvant selpercatinib or placebo in stage IB-IIIA RET fusion-positive non-small-cell lung cancerMasahiro Tsuboi, Jonathan W Goldman, Yi-Long Wu, et al.
Future Oncology (London, England)|June 22, 2021
First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50Renaud Descourt, Christos Chouaid, Maurice Pérol, et al.
European Radiology|May 15, 2021
Can MRI differentiate surrounding vertebral invasion from reactive inflammatory changes in superior sulcus tumor?Fadila Mihoubi Bouvier, Vincent Thomas De Montpréville, Benjamin Besse, et al.
NPJ Precision Oncology|September 23, 2020
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave RoussyGonzalo Recondo, Linda Mahjoubi, Aline Maillard, et al.
European Journal of Cancer (Oxford, England : 1990)|April 16, 2023
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world dataAlice Boilève, Matthieu Faron, Sarah Fodil-Cherif, et al.
Pageof 59